Sommario

• • ·Association of the cumulative modified life’s Essential 8 score with cognitive change: Results from two longitudinal cohorts

    Articolo :100548

    Yiwen Dai, Yuling Liu, Yang Pan, Menghan Zhu, Xuyang Diao, Xinqing Yang, Jingya Ma, Darui Gao, Yanyu Zhang, Mengmeng Ji, Yichi Zhang, Wuxiang Xie, Fanfan Zheng

    Riassunto Riassunto Mappa Mappa   
• • ·Increase in healthcare utilization and Medicare payment with progression of preclinical Alzheimer’s disease

    Articolo :100547

    Julie Beyrer, Zachary Sheff, Nalin Payakachat, Julie M. Chandler, Yun-Fei Chen, Joanna Kubisiak, Angelina Lee, Karen C. Holdridge, Roy Yaari, Paul Aisen, Michael S. Rafii, Reisa A. Sperling, A4 and LEARN Study Teams

    Riassunto Riassunto Mappa Mappa   
• • ·Hypolipidemics reduce the rate of Alzheimer's disease development and dementia progression: A cohort study linked with genetic and neuropathological analyses

    Articolo :100555

    Zohi Sternberg, Rebecca E. Podolsky, Jihnhee Yu, Shuangcheng Hua, Stanley Halvorsen, Bernhard J. Schaller

    Riassunto Riassunto Mappa Mappa  
• • ·Barriers and facilitators to recruitment, engagement, and retention of underrepresented populations in dementia prevention research: a scoping review

    Articolo :100557

    A.F. Rirash, S. Franzen, R. Bourdage, E. Kreuk, N.C. Visser, G.M. Babulal, E. van den Berg, J.M. Papma

    Riassunto Riassunto Mappa Mappa   
• • ·Global, regional, and national burden of dementia attributable to mood disorders: a comparative risk assessment study

    Articolo :100559

    Jing Wu, Jiali Zhou, Shiyi Shan, Ke Tang, Longzhu Zhu, Jiayao Ying, Xinyu Liu, Peige Song

    Riassunto Riassunto Mappa Mappa   
• • ·Dementia risk factor assessment in a local Alzheimer’s prevention population: a German cross-sectional, observational study

    Articolo :100556

    Lena Sannemann, Michelle Gerards, Lara Bohr, Frederic Brosseron, Claus Escher, Franziska Kalthegener, Theresa Müller, Alfredo Ramírez, Philip Zeyen, Frank Jessen, Ayda Rostamzadeh

    Riassunto Riassunto Mappa Mappa   
• • ·Amyloid-related imaging abnormalities in Japanese patients with Alzheimer’s disease treated with Lecanemab: A real-world study

    Articolo :100562

    Ryosuke Shimasaki, Masanori Kurihara, Taro Bannai, Keiko Hatano, Fumio Suzuki, Aya Midori Tokumaru, Kenji Ishii, Ryoko Ihara, Atsushi Iwata

    Riassunto Riassunto Mappa Mappa   
• • ·Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer’s disease with hydromethylthionine mesylate using external control data

    Articolo :100560

    Bjoern O Schelter, Helen Shiells, Serena Lo, Nafeesa Nazlee, Emily Evans, Peter Bentham, Serge Gauthier, Henrik Zetterberg, Gordon K Wilcock, Lutz Froelich, Alistair Burns, Emer MacSweeney, Clive Ballard, Jin-Tai Yu, Tay Siew Choon, Vahe Asvatourian, Natalia Muehlemann, Jan Priel, Karin Kook, Tenecia Sullivan, Diane Downie, Sonya Miller, Carol Pringle, John M․D Storey, Tom Baddeley, Charles R Harrington, Roger Staff, Anca-Larisa Sandu, Claire Hull, Richard Stefanacci, Claude M Wischik, Alzheimer's Disease Neuroimaging Initiative

    Riassunto Riassunto Mappa Mappa   
• • ·Structural social factors modify the association between Alzheimer’s pathology and cognitive function

    Articolo :100563

    Michelle Gerards, Lena Sannemann, Frank Jessen

    Riassunto Riassunto Mappa Mappa   
• • ·Multidimensional modeling of biological aging: integrating gait, eye movement, rest-state functional connectivity, and plasma biomarkers in non-dementia older adults

    Articolo :100566

    Jingyi Lin, Yiliang Liu, Ziyu Ouyang, Xuan Yang, Sizhe Zhang, Tianyan Xu, Qijie Yang, Yuan Zhu, Meidan Wan, Xuewen Xiao, Xiangmin Fan, Beisha Tang, Lu Shen, Bin Jiao, Shilin Luo

    Riassunto Riassunto Mappa Mappa  
• • ·Knowledge and perception of dementia risk and protective factors: a systematic review and meta-analysis

    Articolo :100565

    Muhammed L. Sambou, Jolanda H.M. Dobbe, Elaine A.C. Albers, Kay Deckers, Lidia R. Arends, M. Arfan Ikram, Ellen M.A. Smets, Wichor M. Bramer, Jeremy A. Labrecque, Leonie N.C. Visser, Frank J. Wolters

    Riassunto Riassunto Mappa Mappa   
• • ·ATNIVS biomarker heterogeneity in real-world patients receiving lecanemab

    Articolo :100567

    Masanori Kurihara, Ryoko Ihara, Gen Yoshii, Ryosuke Shimasaki, Keiko Hatano, Taro Bannai, Fumio Suzuki, Kenji Ishibashi, Ko Furuta, Katsuya Satoh, Aya Midori Tokumaru, Kenji Ishii, Atsushi Iwata

    Riassunto Riassunto Mappa Mappa   
• • ·Comparative effects of some pharmacological and non-pharmacological interventions on cognitive function in Alzheimer’s disease: A Bayesian network meta-analysis

    Articolo :100564

    Yuning Zhao, Guangxin Luo, Can Huang, Zhenyang Chen, Yu Wei, Qiaosen Chen, Fang Wang, Yong Gan, Xiaoxv Yin

    Riassunto Riassunto Mappa Mappa   
• • ·Pathways to participation – a scoping review outlining barriers and enablers to participation in dementia research

    Articolo :100558

    Lukas A. Duffner, Soraya Moradi-Bachiller, Dianne Gove, Ana M. Diaz-Ponce, Angela Bradshaw, Jean Georges

    Riassunto Riassunto Mappa Mappa   
• • ·Cost analyses of plasma p-tau217 versus p-tau217/Aβ42 ratio using two-step approach in the Japanese health care system

    Articolo :100572

    Masanori Kurihara, Ryoko Ihara, Kenichiro Sato, Atsushi Iwata

    Riassunto Riassunto Mappa Mappa   
• • ·The concurrent burden of Alzheimer’s pathology, cerebral amyloid angiopathy, and microinfarcts on cognitive decline

    Articolo :100568

    Mingyao You, Chao Tang, Lianfei Liu, Dengpeng Chen, Yillin Wu, Dian He

    Riassunto Riassunto Mappa Mappa   
• • ·The association between omega-3 supplementation and cognitive decline in older adults

    Articolo :100569

    Zheng-Bin Liao, Zi-Cheng Hu, Gui-Hua Zeng, Jia Chen, Xin-Peng Li, Yu-Hui Liu, Xiu-Qing Yao, Ye-Ran Wang, Alzheimer’s Disease Neuroimaging Initiative

    Riassunto Riassunto Mappa Mappa   
• • ·Speech-based digital biomarkers for early etiological stratification of Alzheimer’s disease and frontotemporal degeneration: a biomarker-confirmed prospective study

    Articolo :100573

    Eloïse Da Cunha, Valeria Manera, Frédéric Chorin, Justine Lemaire, Alexandra Plonka, Aurélie Mouton, Raphaël Zory, Auriane Gros

    Riassunto Riassunto Mappa Mappa   
• • ·Health-economic challenges for new Alzheimer’s disease treatments

    Articolo :100575

    Jinjing Fu, Anders Sköldunger, Angela Bradshaw, Hana Marie Broulíková, Chiara C Brück, Jack M. Chapel, Sabine Grimm, Anna Hansson, William L. Herring, Jakub Hlávka, Men Thi Hoang, Linus Jönsson, Filipa Landeiro, Javier Mar, Alison McKean, Matej Misik, Peter Neumann, Thomas Rapp, Craig Ritchie, Anja Schiel, Yi Sun, Dominic Trépel, David Trueman, P.J. van der Veere, Lynn van Rosmalen, Jean L Vonsy, Lizzie Walker, Anders Wimo, Bengt Winblad, Xin Xia, Ron Handels

    Mappa Mappa
• • ·Lipid-lowering regimens in Alzheimer’s disease dementia: small effects with potential long-term benefit

    Articolo :100576

    Tobias Hartmann

    Mappa Mappa
• • ·Amyloid pathology and modifiable risk factors in cognitive decline among cognitively unimpaired older adults

    Articolo :100574

    Ying-Hsin Hsu, Chih-Kuang Liang, Ming-Yueh Chou, Jaysón Davidson, Yu-Chun Wang, Mike A. Nalls, Luigi Ferrucci, Mark Cookson, Hirotaka Iwaki

    Riassunto Riassunto Mappa Mappa   
• • ·Beyond amyloid positivity: Biological heterogeneity in the real-world use of lecanemab

    Articolo :100584

    Michael S. Rafii

    Mappa Mappa
• • ·Associations of plasma biomarkers with age in the presenilin-1 E280A autosomal dominant Alzheimer's disease kindred

    Articolo :100578

    Vincent Malotaux, Vivian Ku, Paula Ospina Lopera, Yi Su, Yinghua Chen, Alpana Singh, Jonathan Ruiz-Triviño, María José Hidalgo, Laura Osorio, Laura Serna, Daniela Giraldo, Diana Alzate, Bing He, Catarina Tristão-Pereira, Liliana Ramirez Gomez, Sonia Do Carmo, A. Claudio Cuello, Nicholas J. Ashton, Eric M. Reiman, David Aguillón, Yakeel T. Quiroz

    Riassunto Riassunto Mappa Mappa